COTI-2, a novel small molecule that is active against multiple human cancer cell linesin vitroandin vivo

Abstract excerpt

// Kowthar Y. Salim 1, * , Saman Maleki Vareki 2, * , Wayne R. Danter 1 , Serban San-Marina 7 and James Koropatnick 2, 3, 4, 5, 6 1 Critical Outcome Technologies Inc., London, Ontario, Canada 2 Cancer Research Laboratory Program, Lawson Health Research Institute, London, Ontario, Canada 3 Department of Microbiology and Immunology, Western University, London, Ontario, Canada 4 Department of Pathology, Western...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer therapeutics and mechanisms
• Share to Computational Drug Discovery Methods
• Share to Lung Cancer Treatments and Mutations